History of Vaccines Blog
Chickenpox Vaccine and Shingles Risk
When I was 4 or 5 years old, in the early 1980s, I contracted chickenpox (also known as varicella). I remember the days that I spent home feeling sick and covered in pocks because my parents decided that it would be a good idea to invite all my cousins to come over and get exposed. The house was soon filled with over a dozen children my age, and I couldn’t join them in playing because I was sick while they were running around, laughing and playing. A few days later, I felt better, but almost all of my cousins went down with the disease.
New Shingles Vaccine Approval and Recommendations
Phase 3 Trial of Recombinant Shingles Vaccine Shows Promise in Older Adults
The herpes zoster vaccine commercially available in the United States (Zostavax, Merck, generic zoster vaccine live) is 51% effective at preventing shingles in adults ages 60 and older, but it is less effective for older adults. For those over age 70, it is only 38% effective at preventing disease.
Philadelphia Study Examines Varicella and Herpes Zoster
By Thomas Fekete, MD, FCPP, Section Chief, Infectious Diseases; Professor, Medicine; Associate Professor, Microbiology and Immunology; School of Medicine, Temple University
From ID Week: Adult Immunization Barriers and Promoters
How is the immune system similar to your marathon time? As we age, our immune response decreases at the same slope that our marathon race times increase. Presenters described this and some of the other problems of immunizing adults in the Symposium on Adult Immunizations, an early session at the Infectious Diseases Society 2014 conference at the Philadelphia Convention Center.